|Phase of Study:||Phase III|
|Treatment Location:||Both at MDACC & outside MDACC at one or more Collaborating Sites or Institutions|
|Estimated Length of Stay in Houston:||n/a|
|Supported By:||Cancer and Leukemia Group B (CALGB)|
|Return Visit:|| Every 3 months for 2 years, every 6 months for 3 years, then at least every |
year for 5 years.